Markets:

Overview

News

Currencies

International

Treasuries

Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

14.69 -1.41 (-8.76%)

Streaming Delayed Price Updated: 3:14 PM EST, Nov 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tonix Pharmaceuticals Holding Corp. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Tonix CEO Calls for New Class of Covid-19 Pre-Exposure and Therapeutic Antibodies for High-Risk Populations

January 24, 2023

Tonix CEO Calls for New Class of Covid-19 Pre-Exposure and Therapeutic Antibodies for High-Risk Populations

Via News Direct

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 23, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 06, 2023

Via Benzinga

Why Is Tonix Pharmaceuticals (TNXP) Stock Up 40% Today? ↗

December 12, 2022

TNXP stock traders are in a bidding war today as Tonix announces a possible game-changer in Covid-19 treatment methodologies.

Via InvestorPlace

Recap: Tonix Pharmaceuticals Q3 Earnings ↗

November 07, 2022

Tonix Pharmaceuticals (NASDAQ:TNXP) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

Crude Oil Rises Sharply; Adicet Bio Shares Plunge ↗

December 12, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Monday

Via Benzinga

Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

December 12, 2022

Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.

Via Benzinga

Why Is Reborn Coffee (REBN) Stock Up 34% Today? ↗

December 12, 2022

Reborn Coffee (REBN) stock is heating up on Monday as investors take note of the California coffee company's shares with heavy trading.

Via InvestorPlace

Why Is Harpoon Therapeutics (HARP) Stock Up 100%+ Today? ↗

December 12, 2022

Harpoon Therapeutics (HARP) stock is taking off on Monday following the release of updated results from its myeloma drug candidate.

Via InvestorPlace

Why Tonix Pharmaceuticals Stock Is Rocketing Higher Today ↗

December 12, 2022

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading higher Monday after the company announced the exclusive license of potential therapeutic or preventative humanized anti-SARS-CoV-2

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 12, 2022

Via Benzinga

Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session ↗

November 16, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa ↗

November 03, 2022

Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases...

Via Benzinga

Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

October 05, 2022

A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll...

Via PressReach

Topics Cannabis

Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

October 05, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease,...

Via FinancialNewsMedia

Topics Cannabis

New Ways To Treat Long Covid Might Be Here Sooner Than Thought ↗

September 20, 2022

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The sponsored content team works to ensure...

Via Benzinga

White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox ↗

September 02, 2022

Via Benzinga

Psychedelics Use Among Young Adults Reaches All-Time High

September 01, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever. According to a National Institute of Health survey,...

Via FinancialNewsMedia

Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed ↗

August 26, 2022

Via Benzinga

Looking Into Tonix Pharmaceuticals's Recent Short Interest ↗

August 23, 2022

Tonix Pharmaceuticals's (NASDAQ:TNXP) short percent of float has risen 204.49% since its last report. The company recently reported that it has 2.36 million shares sold short,...

Via Benzinga

Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch ↗

August 23, 2022

The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply.

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 22, 2022

Via Benzinga

Tonix Pharmaceuticals Commences Mid-Stage Long COVID Study, Sees Interim Report In H1 2023 ↗

August 22, 2022

Tonix Pharmaceuticals (NASDAQ: TNXP) has initiated patient enrolment in the Phase 2 PREVAIL study of TNX-102 SL for patients with Long COVID syndrome (Long COVID).

Via Benzinga

Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test ↗

August 19, 2022

Via Benzinga

Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment ↗

August 18, 2022

Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments.

Via Benzinga

WeTrade Shares Soar On Collaboration Over Exclusive COVID-19 Omicron Disinfectant ↗

August 18, 2022

Via Benzinga

A Biopharma Working On Malaria, Norovirus Vaccines Threw It's Hat In The Monkeypox Ring ↗

August 17, 2022

Blue Water Vaccines Inc (NASDAQ: BWV)

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.